Using red blood cells modified to carry disease-specific antigens, a team of scientists have prevented and alleviated two autoimmune diseases — multiple sclerosis (MS) and type 1 diabetes — in early stage mouse models. This research is an exciting step toward therapeutics for autoimmune diseases, which affect an estimated 23 million Americans.